Nanologica Future Growth

Future criteria checks 2/6

Nanologica is forecast to grow revenue at 83.7% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth48.9%
Revenue growth rate83.7%
Future return on equityn/a
Analyst coverage

Low

Last updated08 Jul 2024

Recent future growth updates

Recent updates

Nanologica (STO:NICA) Is Making Moderate Use Of Debt

Oct 10
Nanologica (STO:NICA) Is Making Moderate Use Of Debt

Is Nanologica AB (publ) (STO:NICA) Trading At A 40% Discount?

Jun 12
Is Nanologica AB (publ) (STO:NICA) Trading At A 40% Discount?

Does Nanologica (STO:NICA) Have A Healthy Balance Sheet?

Oct 20
Does Nanologica (STO:NICA) Have A Healthy Balance Sheet?

Nanologica (STO:NICA) Is Making Moderate Use Of Debt

Jun 23
Nanologica (STO:NICA) Is Making Moderate Use Of Debt

Is Nanologica (NGM:NICA) A Risky Investment?

Jan 03
Is Nanologica (NGM:NICA) A Risky Investment?

Is Nanologica (NGM:NICA) Weighed On By Its Debt Load?

Jun 14
Is Nanologica (NGM:NICA) Weighed On By Its Debt Load?

Shareholders Are Thrilled That The Nanologica (NGM:NICA) Share Price Increased 115%

Feb 23
Shareholders Are Thrilled That The Nanologica (NGM:NICA) Share Price Increased 115%

Earnings and Revenue Growth Forecasts

OM:NICA - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026232N/AN/AN/A1
12/31/2025139N/AN/AN/A1
12/31/202449N/AN/AN/A1
6/30/20248-76-54-46N/A
3/31/20248-80-61-49N/A
12/31/20235-75-57-36N/A
9/30/20236-53-59-42N/A
6/30/20237-53-57-36N/A
3/31/20237-51-51-34N/A
12/31/20226-55-54-45N/A
9/30/20225-56-55-49N/A
6/30/20226-57-60-56N/A
3/31/20229-53-61-58N/A
12/31/202115-45-52-46N/A
9/30/202121-35-48-44N/A
6/30/202121-28-40-34N/A
3/31/202121-23-45-39N/A
12/31/202018-22-47-43N/A
9/30/202014-24-47-33N/A
6/30/202014-24-39-27N/A
3/31/202014-23-48-16N/A
12/31/201912-21-20-10N/A
9/30/201912-18-11-9N/A
6/30/201911-18-17-14N/A
3/31/20198-19-14-11N/A
12/31/20186-21-15-12N/A
9/30/20187-18-26-24N/A
6/30/20186-18-28-26N/A
3/31/20185-19N/A-21N/A
12/31/20175-20N/A-23N/A
9/30/20173-22N/A-17N/A
6/30/20174-24N/A-18N/A
3/31/20174-24N/A-24N/A
12/31/20164-22N/A-23N/A
9/30/20165-23N/A-25N/A
6/30/20165-21N/A-19N/A
3/31/20167-18N/A-17N/A
12/31/20159-14N/A-14N/A
9/30/20158-14N/AN/AN/A
6/30/20159-15N/AN/AN/A
3/31/20157-14N/AN/AN/A
12/31/20147-15N/AN/AN/A
12/31/20135-10N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if NICA's forecast earnings growth is above the savings rate (1.1%).

Earnings vs Market: Insufficient data to determine if NICA's earnings are forecast to grow faster than the Swedish market

High Growth Earnings: Insufficient data to determine if NICA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: NICA's revenue (83.7% per year) is forecast to grow faster than the Swedish market (1.2% per year).

High Growth Revenue: NICA's revenue (83.7% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if NICA's Return on Equity is forecast to be high in 3 years time


Discover growth companies